|
GLUE Monte Rosa Therapeutics Inc 1826457 |
| Balance Sheet |
|
Current Assets
|
$631,406,000.00 |
|
Assets
|
$691,161,000.00 |
|
Current Liabilities
|
$59,658,000.00 |
|
Liabilities
|
$203,880,000.00 |
|
Equity
|
$487,281,000.00 |
|
Shares Out
|
85226427.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-81,483,000.00 |
|
Investing Cash Flow
|
$-289,857,000.00 |
| Market Analysis |
Market Cap
|
$1,259,646,591.06 |
|
Price
|
$14.78 |
|
BVPS
|
5.72 |
|
PB
|
2.58 |
|
EPS
|
-1.46 |
|
PS
|
35.12 |
|
FCF
|
$-88,074,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-17 |
|
|
|
2026-05-07 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLUE documents filed with the SEC.
GLUE Filings
Clear
